Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration

被引:103
作者
Coletti, D
Moresi, V
Adamo, S
Molinaro, M
Sassoon, D
机构
[1] Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA
[2] Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy
[3] Univ Roma La Sapienza, Interuniv Inst Myol, Rome, Italy
[4] UPMC, Fac Med Pitie Salpetriere, INSERM, Unite Muscle Biol & Stem Cells, Paris, France
关键词
cachexia; electroporation; gene delivery; cytokines; skeletal muscle;
D O I
10.1002/gene.20160
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic disease states are associated with elevated levels of inflammatory cytokines that have been demonstrated to lead to severe muscle wasting. A mechanistic understanding of muscle wasting is hampered by limited in vivo cytolkine models which can be applied to emerging mouse mutants as they are generated. We developed a simple and novel approach to induce adult mouse skeletal muscle wasting based on direct gene transfer of an expression vector encoding the secreted form of the murine tumor necrosis factor-a (mTNF alpha). This procedure results in the production of elevated levels of circulating mTNF alpha followed by body weight loss, upregulation of Atrogin1, and muscle atrophy, including muscles distant from the site of gene transfer. We also found, that mTNFa gene transfer resulted in a significant inhibition of regeneration following muscle injury. We conclude that in addition to being a potent inducer of cachexia, TNF alpha is a potent inhibitor of myogenesis in vivo.
引用
收藏
页码:120 / 128
页数:9
相关论文
共 39 条
[1]   Cancer cachexia is regulated by selective targeting of skeletal muscle gene products [J].
Acharyya, S ;
Ladner, KJ ;
Nelsen, LL ;
Damrauer, J ;
Reiser, PJ ;
Swoap, S ;
Guttridge, DC .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) :370-378
[2]   Catabolic mediators as targets for cancer cachexia [J].
Argilés, JM ;
Moore-Carrasco, R ;
Busquets, S ;
López-Soriano, FJ .
DRUG DISCOVERY TODAY, 2003, 8 (18) :838-844
[3]  
BIBBY MC, 1987, J NATL CANCER I, V78, P539
[4]  
Braun S, 2004, CURR OPIN MOL THER, V6, P499
[5]   Cellular and molecular regulation of muscle regeneration [J].
Chargé, SBP ;
Rudnicki, MA .
PHYSIOLOGICAL REVIEWS, 2004, 84 (01) :209-238
[6]   TNFα inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways [J].
Coletti, D ;
Yang, E ;
Marazzi, G ;
Sassoon, D .
EMBO JOURNAL, 2002, 21 (04) :631-642
[7]   The role of tumor necrosis factor-alpha (TNF-α) in skeletal muscle regeneration:: Studies in TNF-α(-/-) and TNF-α(-/-)/LT-α(-/-) mice [J].
Collins, RA ;
Grounds, MD .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (08) :989-1001
[8]   Aging, stem cells and tissue regeneration - Lessons from muscle [J].
Conboy, IM ;
Rando, TA .
CELL CYCLE, 2005, 4 (03) :407-410
[9]   A role for engrailed-2 in determination of skeletal muscle physiologic properties [J].
Degenhardt, K ;
Sassoon, DA .
DEVELOPMENTAL BIOLOGY, 2001, 231 (01) :175-189
[10]   PROGNOSTIC EFFECT OF WEIGHT-LOSS PRIOR TO CHEMOTHERAPY IN CANCER-PATIENTS [J].
DEWYS, WD ;
BEGG, C ;
LAVIN, PT ;
BAND, PR ;
BENNETT, JM ;
BERTINO, JR ;
COHEN, MH ;
DOUGLASS, HO ;
ENGSTROM, PF ;
EZDINLI, EZ ;
HORTON, J ;
JOHNSON, GJ ;
MOERTEL, CG ;
OKEN, MM ;
PERLIA, C ;
ROSENBAUM, C ;
SILVERSTEIN, MN ;
SKEEL, RT .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :491-497